Related Experiment Videos

Multiple antibiotic sensitivity in a pediatric population

M M Kamada1, F Twarog, D Y Leung

  • 1Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.

Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
|September 1, 1991
PubMed

Insights

Multiple antibiotic sensitivity (MAS) in children often involves IgE-mediated reactions, particularly to beta-lactams. Skin tests can confirm hypersensitivity, guiding accurate diagnosis and management for pediatric antibiotic allergies.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Pharmacology
  • Dermatology

Background:

  • Multiple antibiotic sensitivity (MAS) is a frequent clinical challenge, especially in children, but lacks comprehensive review.
  • Understanding the patterns and mechanisms of MAS in pediatric populations is crucial for effective management.

Purpose of the Study:

  • To investigate the characteristics of multiple antibiotic sensitivity in a cohort of 120 children.
  • To identify common offending antibiotics, reaction types, and the role of IgE-mediated hypersensitivity.

Main Methods:

  • Retrospective evaluation of 120 children with a history of MAS.
  • Analysis of antibiotic classes involved, types of adverse reactions, and patient demographics.
  • Performance of skin tests (ST) using penicillin G and related components in 98 children.

Main Results:

  • Beta-lactams were the most frequent cause of adverse reactions (186), followed by sulfonamides (86).
  • Urticaria was the most common reaction (183), followed by rash (71) and angioedema (19).
  • Positive skin tests were observed in 26% of patients, indicating IgE-mediated hypersensitivity.

Conclusions:

  • Pediatric MAS is frequently associated with true IgE-mediated hypersensitivity, particularly to penicillin.
  • Skin testing is valuable for confirming antibiotic hypersensitivity in children with MAS.
  • Accurate evaluation for specific antibiotic sensitivities is essential, rather than assuming generalized drug formulation sensitivity.

Related Concept Videos